Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Antiviral Activity of 1-Adamantanamine (Amantadine)
1964652 citationsW. L. Davies, R. R. Grunert et al.Scienceprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of E Neumayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Neumayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Neumayer more than expected).
This network shows the impact of papers produced by E Neumayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Neumayer. The network helps show where E Neumayer may publish in the future.
Co-authorship network of co-authors of E Neumayer
This figure shows the co-authorship network connecting the top 25 collaborators of E Neumayer.
A scholar is included among the top collaborators of E Neumayer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with E Neumayer. E Neumayer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Birkmayer, W, W Danielczyk, E Neumayer, & Peter Riederer. (1975). Dopaminergic supersensitivity in parkinsonism.. PubMed. 9. 121–9.16 indexed citations
2.
Neumayer, E, et al.. (1975). [The action of prostaglandin E2-induced pains on the metabolic and clotting systems of mother and child during birth (author's transl)].. PubMed. 179(2). 125–31.1 indexed citations
Neumayer, E. (1966). [The fetal Hb content in umbilical venous blood in newborn infants of mothers with late pregnancy toxemia].. PubMed. 88(40). 1348–50.2 indexed citations
10.
Neumayer, E. (1966). Spinale Phlebitis. Journal of Neurology. 189(2).8 indexed citations
Neumayer, E. (1965). [PROGRESSIVE VASCULAR MYELOPATHY IN OLD AGE].. PubMed. 115. 181–4.1 indexed citations
13.
Jellinger, K. A. & E Neumayer. (1964). Progressive subcorticale vasculre Encephalopathie Binswanger: Eine klinisch-neuropathologische Studie. 205(5). 523–554.45 indexed citations
14.
Davies, W. L., R. R. Grunert, R. F. Haff, et al.. (1964). Antiviral Activity of 1-Adamantanamine (Amantadine). Science. 144(3620). 862–863.652 indexed citations breakdown →
15.
Birkmayer, W & E Neumayer. (1963). [HEAT REGULATION IN POSTENCEPHALITIC PARKINSONISM].. PubMed. 34. 373–4.5 indexed citations
16.
Birkmayer, W, H. Dittrich, & E Neumayer. (1958). [Bone marrow as an indicator of defense reaction of the organism to multiple sclerosis].. PubMed. 15(1-4). 59–64.
Neumayer, E, et al.. (1956). [Blood protein picture in multiple sclerosis].. PubMed. 13(1-2). 46–64.4 indexed citations
20.
Neumayer, E. (1954). [The constitution of multiple sclerosis; preliminary report].. PubMed. 104(49). 974–5.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.